Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Fernandez

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Current Drug Safety|October 27, 2020
Efficacy and Cardiovascular Safety of MeglitinidesJim Philip, Cornelius James Fernandez
Transplantation|August 30, 2014
Novel valganciclovir desensitization protocolAlexei Gonzalez-Estrada, James Fernandez
BMJ Case Reports|December 7, 2013
PCP: thinking beyond HIVAlexei Gonzalez-Estrada, James Fernandez
Current Drug Safety|November 6, 2020
Efficacy and Cardiovascular Safety of InsulinsCornelius James Fernandez, Chandni Radhakrishnan
The Journal of Allergy and Clinical Immunology. in Practice|April 4, 2016
NOD2-associated autoinflammatory disease and immune deficiencyQingping Yao, Min Shen, James Fernandez
BMJ Case Reports|December 18, 2020
Myasthenia gravis presenting as bilateral pseudointernuclear ophthalmoplegia in a patient with an incidental prolactinomaJulian Fernando Arias Chavez, Cornelius James Fernandez
Cleveland Clinic Journal of Medicine|January 2, 2026
Do corticosteroids prevent reactions to infusions of contrast, monoclonal antibodies, or chemotherapy?Dylan T Timberlake, Sushmitha Boppana, James Fernandez
Annual Review of Nutrition|October 6, 2004
Regulation of cationic amino acid transport: the story of the CAT-1 transporterMaria Hatzoglou, James Fernandez, Ibrahim Yaman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 24, 2017
Allergic disease in patients with common variable immunodeficiency at a tertiary care referral centerJaclyn A Bjelac, Maria Barcena Blanch, James Fernandez
World Journal of Diabetes|August 28, 2024
Diabetic cardiomyopathy: Emerging therapeutic optionsCornelius James Fernandez, Sahana Shetty, Joseph M Pappachan
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Current Drug Safety|October 27, 2020
Efficacy and Cardiovascular Safety of MeglitinidesJim Philip, Cornelius James Fernandez
Transplantation|August 30, 2014
Novel valganciclovir desensitization protocolAlexei Gonzalez-Estrada, James Fernandez
BMJ Case Reports|December 7, 2013
PCP: thinking beyond HIVAlexei Gonzalez-Estrada, James Fernandez
Current Drug Safety|November 6, 2020
Efficacy and Cardiovascular Safety of InsulinsCornelius James Fernandez, Chandni Radhakrishnan
The Journal of Allergy and Clinical Immunology. in Practice|April 4, 2016
NOD2-associated autoinflammatory disease and immune deficiencyQingping Yao, Min Shen, James Fernandez
BMJ Case Reports|December 18, 2020
Myasthenia gravis presenting as bilateral pseudointernuclear ophthalmoplegia in a patient with an incidental prolactinomaJulian Fernando Arias Chavez, Cornelius James Fernandez
Cleveland Clinic Journal of Medicine|January 2, 2026
Do corticosteroids prevent reactions to infusions of contrast, monoclonal antibodies, or chemotherapy?Dylan T Timberlake, Sushmitha Boppana, James Fernandez
Annual Review of Nutrition|October 6, 2004
Regulation of cationic amino acid transport: the story of the CAT-1 transporterMaria Hatzoglou, James Fernandez, Ibrahim Yaman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 24, 2017
Allergic disease in patients with common variable immunodeficiency at a tertiary care referral centerJaclyn A Bjelac, Maria Barcena Blanch, James Fernandez
World Journal of Diabetes|August 28, 2024
Diabetic cardiomyopathy: Emerging therapeutic optionsCornelius James Fernandez, Sahana Shetty, Joseph M Pappachan
Pageof 5